Skadden advised China-based biotechnology company 3SBio Inc. on its HK$5.52 billion public offering on the Hong Kong Stock Exchange.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
Skadden advised China-based biotechnology company 3SBio Inc. on its HK$5.52 billion public offering on the Hong Kong Stock Exchange.